Gladstone Institutes:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Gladstone Institutes - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9282
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:46
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Gladstone Institutes (Gladstone) is a non-profit life science research organization that offers medical research programs. The organization carries out research and development in the areas of cardiovascular disease, virology and immunology, neurological disease, stem cell biology and regenerative medicine, biofulcrum, and others. It also provides training programs for graduate students; and run drug tests on heart cells created from a patient’s own skin cells, medical students and postdoctoral fellows. Gladstone offers core facilities services in assay development and drug discovery, neurobehavioral, bioinformatics, flow cytometry, genomics, histology and light microscopy, mass spectometry, stem cell, and transgenic gene targeting. The organization partners with other research institutes. Gladstone is headquartered in San Francisco, California, the US.

Gladstone Institutes – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Gladstone Institutes, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Gladstone Institutes, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Gladstone Institutes, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Gladstone Institutes, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Gladstone Institutes, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Gladstone Institutes, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Aelan Cell Technologies Enters into Agreement with Gladstone Institutes 10
Gladstone Institutes Enters into Joint Venture with Dolby Family Ventures and Evotec 11
Gladstone Enters into Research Agreement with Takeda Pharma 12
ALS Therapy Enters Into Research Agreement With Gladstone For ALS Treatments 13
Licensing Agreements 14
Fate Therapeutics Enters into License Agreement with Gladstone Institutes 14
Equity Offering 15
Tenaya Therapeutics Spin Off from Gladstone Institutes 15
Gladstone Institutes – Key Competitors 16
Gladstone Institutes – Key Employees 17
Gladstone Institutes – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Joint Venture 18
Recent Developments 19
Strategy And Business Planning 19
Jan 22, 2018: Gladstone Launches Three New Research Centers 19
Government and Public Interest 21
Oct 15, 2018: New immunotherapy targeting blood-clotting protein protects multiple sclerosis and Alzheimer’s disease models 21
Oct 10, 2018: $3.6 Million to Study Adverse Effects of Genome Editing 23
Sep 12, 2018: Scientists Map Interactions between Head and Neck Cancer and HPV Virus 25
Aug 20, 2018: Two Molecules Offer Great Potential to Combat Cancer and Chronic Infections 27
Aug 16, 2018: New Approach to Fight Tuberculosis, a Leading Cause of Death Worldwide 29
Aug 15, 2018: A New Research Partnership to Find Treatments for Neurological Disorders 31
Apr 09, 2018: Scientists Fix Genetic Risk Factor for Alzheimer’s Disease in Human Brain Cells 32
Mar 01, 2018: Gladstone Institutes: Unlocking a Cell’s Potential to Regenerate the Heart 34
Mar 01, 2018: Unlocking a cell’s potential to regenerate the heart 36
Jan 18, 2018: Researchers Create First Stem Cells Using CRISPR Genome Activation 37
Nov 30, 2017: An Anti-Aging Protein Could Be Targeted to Rejuvenate Immune Cells 38
Nov 02, 2017: Gladstone Institutes: Blood-Clotting Protein Prevents Repair in the Brain 40
May 17, 2017: Cancer-cardiac connection illuminates promising new drug for heart failure 42
May 10, 2017: Study Reveals a New Method to Address a Major Barrier to Eradicating HIV 43
Other Significant Developments 44
Jul 03, 2018: Roddenberry Gift Ushers Gladstone Stem Cell Research into the Future 44
Appendix 46
Methodology 46
About GlobalData 46
Contact Us 46
Disclaimer 46

List of Tables
Gladstone Institutes, Pharmaceuticals & Healthcare, Key Facts 2
Gladstone Institutes, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Gladstone Institutes, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Gladstone Institutes, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Gladstone Institutes, Deals By Therapy Area, 2012 to YTD 2018 8
Gladstone Institutes, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Aelan Cell Technologies Enters into Agreement with Gladstone Institutes 10
Gladstone Institutes Enters into Joint Venture with Dolby Family Ventures and Evotec 11
Gladstone Enters into Research Agreement with Takeda Pharma 12
ALS Therapy Enters Into Research Agreement With Gladstone For ALS Treatments 13
Fate Therapeutics Enters into License Agreement with Gladstone Institutes 14
Tenaya Therapeutics Spin Off from Gladstone Institutes 15
Gladstone Institutes, Key Competitors 16
Gladstone Institutes, Key Employees 17
Gladstone Institutes, Subsidiaries 18
Gladstone Institutes, Joint Venture 18

List of Figures
Gladstone Institutes, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Gladstone Institutes, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Gladstone Institutes, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Gladstone Institutes, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Gladstone Institutes, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Gladstone Institutes, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Gladstone Institutes, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Gladstone Institutes, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Gladstone Institutes:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • EDAP TMS SA (EDAP):医療機器:M&Aディール及び事業提携情報
    Summary EDAP TMS SA (EDAP) is a medical device company. It carries out the development, production and distribution of minimally invasive medical devices for the treatment of urological diseases. It offers High Intensity Focused Ultrasound (HIFU) devices for the treatment of localized prostate cance …
  • Tox Free Solutions Ltd (TOX):企業の財務・戦略的SWOT分析
    Tox Free Solutions Ltd (TOX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Forrester Research, Inc.:企業の戦略・SWOT・財務分析
    Forrester Research, Inc. - Strategy, SWOT and Corporate Finance Report Summary Forrester Research, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Medistim ASA (MEDI):企業の財務・戦略的SWOT分析
    Summary MediStim ASA (MediStim) is a medical device company that manufactures and markets medical products for cardiac, vascular and transplant surgeries. The company’s products include MiraQ cardiac, MiraQ vascular, MiraQ ultimate system, imaging probes, flow probes, VeriQ C and VeriQ systems. Its …
  • American Axle & Manufacturing Holdings Inc (AXL):企業の財務・戦略的SWOT分析
    American Axle & Manufacturing Holdings Inc (AXL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key s …
  • Orthofix Medical Inc (OFIX):企業の財務・戦略的SWOT分析
    Orthofix Medical Inc (OFIX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Synchrony Financial:企業の戦略・SWOT・財務分析
    Synchrony Financial - Strategy, SWOT and Corporate Finance Report Summary Synchrony Financial - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Morcher Gmbh:企業の製品パイプライン分析2018
    Summary Morcher Gmbh (Morcher) is a medical device company that develops, manufactures, and distributes implants for cataract surgery. The company’s products include capsular tension rings, eyejet ctr - preloaded capsular tension rings, cionni rings for scleral fixation, capsular segment for scleral …
  • Simplex Infrastructures Ltd:企業の戦略・SWOT・財務分析
    Simplex Infrastructures Ltd - Strategy, SWOT and Corporate Finance Report Summary Simplex Infrastructures Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • The Home Depot, Inc.:企業のM&A・事業提携・投資動向
    The Home Depot, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's The Home Depot, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • Southern Petrochemical Industries Corp Ltd (SPIC):企業の財務・戦略的SWOT分析
    Summary Southern Petrochemical Industries Corp Ltd (SPIC) is a chemical company that manufactures fertilizers for agriculture. The company offers products such as chemical fertilizer, organic and water soluble fertilizers, plant growth regulators, micro nutrients, and industrial products. Its chemic …
  • MedinCell SA:製薬・医療:M&Aディール及び事業提携情報
    Summary MedinCell SA (MedinCell) is a developer of therapeutic solutions for the healthcare market. The company develops and commercializes BEPO, a technology based on custom proprietary copolymers and a biocompatible solvent for long acting injectables. Its BEPO provides a controlled release of the …
  • Okamura Corporation:企業の戦略・SWOT・財務情報
    Okamura Corporation - Strategy, SWOT and Corporate Finance Report Summary Okamura Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • CTBC Bank Co Ltd:企業の戦略・SWOT・財務情報
    CTBC Bank Co Ltd - Strategy, SWOT and Corporate Finance Report Summary CTBC Bank Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • SK Chemicals Co Ltd (006120):企業の財務・戦略的SWOT分析
    Summary SK Chemicals Co Ltd (SK Chemicals) is a chemical company that provides life sciences products and solutions. The company manufactures polyester and acetate yarns for textile, and industrial uses. Its copolyesters comprise ecozen, skygreen and skypets. SK Chemicals provides high-performance r …
  • Melrose Industries PLC (MRO):企業の財務・戦略的SWOT分析
    Summary Melrose Industries PLC (Melrose) is an investment company that improve and sell industrial and manufacturing businesses. The company offers products such as air management, security, home automation and ergonomic and electricity generating equipment. Its business portfolio comprises of Norte …
  • British Airways Plc:企業の戦略的SWOT分析
    British Airways Plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Tecpetrol S.A.:企業の戦略・SWOT・財務分析
    Tecpetrol S.A. - Strategy, SWOT and Corporate Finance Report Summary Tecpetrol S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Eu Yan Sang International Ltd:企業の戦略的SWOT分析
    Eu Yan Sang International Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Medicamen Biotech Ltd (531146):企業の財務・戦略的SWOT分析
    Medicamen Biotech Ltd (531146) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆